506 related articles for article (PubMed ID: 29667744)
1. Intraurethral Erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: A pilot study.
Gaspar A; Maestri S; Silva J; Brandi H; Luque D; Koron N; Vižintin Z
Lasers Surg Med; 2018 Oct; 50(8):802-807. PubMed ID: 29667744
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause.
Gaspar A; Brandi H; Gomez V; Luque D
Lasers Surg Med; 2017 Feb; 49(2):160-168. PubMed ID: 27546524
[TBL] [Abstract][Full Text] [Related]
3. Rationale and design for fractional microablative CO
Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of intraurethral Erbium:YAG laser treatment in women with stress urinary incontinence following failed intravaginal laser therapy: a retrospective study.
Tseng YL; Su CF
Lasers Med Sci; 2023 Sep; 38(1):207. PubMed ID: 37688606
[TBL] [Abstract][Full Text] [Related]
5. The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM).
Lin KL; Chou SH; Loo ZX; Liu YY; Cheng JC; Long CY
Lasers Med Sci; 2022 Jun; 37(4):2203-2208. PubMed ID: 34988731
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause.
Gambacciani M; Levancini M; Russo E; Vacca L; Simoncini T; Cervigni M
Climacteric; 2018 Apr; 21(2):148-152. PubMed ID: 29436235
[TBL] [Abstract][Full Text] [Related]
7. Vaginal laser therapy for GSM/VVA: where we stand now - a review by the EUGA Working Group on Laser.
Salvatore S; Ruffolo AF; Phillips C; Athanasiou S; Cardozo L; Serati M;
Climacteric; 2023 Aug; 26(4):336-352. PubMed ID: 37395104
[TBL] [Abstract][Full Text] [Related]
8. Laser Therapy for Genitourinary Syndrome of Menopause.
Rabley A; O'Shea T; Terry R; Byun S; Louis Moy M
Curr Urol Rep; 2018 Aug; 19(10):83. PubMed ID: 30117032
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence.
Gambacciani M; Torelli MG; Martella L; Bracco GL; Casagrande AG; Albertin E; Tabanelli S; Viglietta M; D'Ambrogio G; Garone G; Cervigni M
Climacteric; 2015; 18 Suppl 1():43-8. PubMed ID: 26366800
[TBL] [Abstract][Full Text] [Related]
10. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause.
Gambacciani M; Levancini M; Cervigni M
Climacteric; 2015 Oct; 18(5):757-63. PubMed ID: 26029987
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
Jha S; Wyld L; Krishnaswamy PH
Clin Breast Cancer; 2019 Aug; 19(4):e556-e562. PubMed ID: 31227415
[TBL] [Abstract][Full Text] [Related]
12. Genitourinary syndrome of menopause (GSM) and laser VEL: a review.
Elia D; Gambacciani M; Berreni N; Bohbot JM; Druckmann R; Geoffrion H; Haab F; Heiss N; Rygaloff N; Russo E
Horm Mol Biol Clin Investig; 2019 Dec; 41(1):. PubMed ID: 31855563
[TBL] [Abstract][Full Text] [Related]
13. Laser therapy for the restoration of vaginal function.
Gambacciani M; Palacios S
Maturitas; 2017 May; 99():10-15. PubMed ID: 28364861
[TBL] [Abstract][Full Text] [Related]
14. Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors.
Gambacciani M; Levancini M
Menopause; 2017 Mar; 24(3):316-319. PubMed ID: 28231079
[TBL] [Abstract][Full Text] [Related]
15. A study of the objective benefits and safety of Er-YAG laser in the treatment of genitourinary syndrome of menopause.
Avul Z; Guven CM
Lasers Med Sci; 2023 Jun; 38(1):131. PubMed ID: 37270721
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of fractional CO
Tovar-Huamani J; Mercado-Olivares F; Grandez-Urbina JA; Pichardo-Rodriguez R; Tovar-Huamani M; García-Perdomo H
Lasers Surg Med; 2019 Aug; 51(6):509-515. PubMed ID: 30779363
[TBL] [Abstract][Full Text] [Related]
17. Histological findings after non-ablative Er:YAG laser therapy in women with severe vaginal atrophy.
Gaspar A; Silva J; Calderon A; Di Placido V; Vizintin Z
Climacteric; 2020; 23(sup1):S11-S13. PubMed ID: 33124455
[No Abstract] [Full Text] [Related]
18. Short-term effects of an erbium/neodymium laser combination in superficial dyspareunia: a pilot study.
Gambacciani M; Fidecicchi T
Climacteric; 2022 Apr; 25(2):208-211. PubMed ID: 35006008
[TBL] [Abstract][Full Text] [Related]
19. Non-ablative erbium YAG laser for the treatment of type III stress urinary incontinence (intrinsic sphincter deficiency).
Gaspar A; Brandi H
Lasers Med Sci; 2017 Apr; 32(3):685-691. PubMed ID: 28210823
[TBL] [Abstract][Full Text] [Related]
20. Laser therapy as a treatment modality for genitourinary syndrome of menopause: a critical appraisal of evidence.
Arunkalaivanan A; Kaur H; Onuma O
Int Urogynecol J; 2017 May; 28(5):681-685. PubMed ID: 28154914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
